Modalities of fatigue in multiple sclerosis:: correlation with clinical and biological factors

被引:125
作者
Iriarte, J [1 ]
Subirá, ML
de Castro, P
机构
[1] Univ Navarra Clin, Dept Neurol, Pamplona 31080, Spain
[2] Univ Navarra Clin, Dept Immunol, Pamplona 31080, Spain
来源
MULTIPLE SCLEROSIS | 2000年 / 6卷 / 02期
关键词
fatigue; multiple sclerosis; pathogenesis;
D O I
10.1191/135245800678827572
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although different factors ore probably involved in the etiology of fatigue in multiple sclerosis patients, no definite mechanism has been proposed We have proposed that fatigue is a complex symptom that includes three clinical different entities (asthenia, fatigability and worsening of symptoms with effort). The goal of this study is to demonstrate if there is a peculiar mechanism for each of the different varieties of fatigue. A control sample of 155 patients (105 women, 50 men) with clinically definite MS was studied. Fatigue was measured using the Fatigue Descriptive Scale (FDS) and the Fatigue Severity Scale (FSS). Treatment, depression, anxiety sleep and cellular immune status were studied too. Fatigue was a symptom in 118 patients (76.13%); 26 patients (22.03%) described it as asthenia (fatigue at rest); 85 patients (72.03%) as fatigability (fatigue with exercise), and seven patients (5.9%) as worsening of symptoms. The severity of pyramidal involvement was significantly more severe in patients suffering from fatigue; some immunological Parameters were associated with fatigue as well. The discriminant analysis of the data shows that some of the immunoactivation parameters ore associated with asthenia (F=21.5, P < 0.001), and pyramidal trace involvement is associated with fatigability (F=10.5, P < 0.001). Sleep disorders, anxiety and depression were linked with fatigue in a few patients. No relationship with treatment was proven. In conclusion, fatigue in MS seems to be a heterogeneous entity. Asthenia and fatigability may be different clinical entities. Certain immunoactivation parameters correlate with the presence of asthenia while pyramidal involvement is associated with fatigability.
引用
收藏
页码:124 / 130
页数:7
相关论文
共 56 条
[1]  
Altman DG., 1991, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589
[2]   Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: Results of a randomized, double-blind, placebo-controlled, crossover trial [J].
Bever, CT ;
Anderson, PA ;
Leslie, J ;
Panitch, HS ;
DhibJalbut, S ;
Khan, OA ;
Milo, R ;
Hebel, JR ;
Conway, KL ;
Katz, E ;
Johnson, KP .
NEUROLOGY, 1996, 47 (06) :1457-1462
[3]   Validation of the functional assessment of multiple sclerosis quality of life instrument [J].
Cella, DF ;
Dineen, K ;
Arnason, B ;
Reder, A ;
Webster, KA ;
Karabatsos, G ;
Chang, C ;
Lloyd, S ;
Mo, F ;
Stewart, J ;
Stefoski, D .
NEUROLOGY, 1996, 47 (01) :129-139
[4]  
COLOSIMO C, 1995, ACTA NEUROL SCAND, V92, P353
[5]   EDMUS, A EUROPEAN DATABASE FOR MULTIPLE-SCLEROSIS [J].
CONFAVREUX, C ;
COMPSTON, DAS ;
HOMMES, OR ;
MCDONALD, WI ;
THOMPSON, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1992, 55 (08) :671-676
[6]   Fatigue in multiple sclerosis compared with chronic fatigue syndrome: A quantitative assessment [J].
Djaldetti, R ;
Ziv, I ;
Achiron, A ;
Melamed, E .
NEUROLOGY, 1996, 46 (03) :632-635
[7]   BUPROPION FOR THE TREATMENT OF FATIGUE ASSOCIATED WITH MULTIPLE-SCLEROSIS [J].
DUFFY, JD ;
CAMPBELL, J .
PSYCHOSOMATICS, 1994, 35 (02) :170-171
[8]   MEASURING THE FUNCTIONAL IMPACT OF FATIGUE - INITIAL VALIDATION OF THE FATIGUE IMPACT SCALE [J].
FISK, JD ;
RITVO, PG ;
ROSS, L ;
HAASE, DA ;
MARRIE, TJ ;
SCHLECH, WF .
CLINICAL INFECTIOUS DISEASES, 1994, 18 :S79-S83
[9]   THE IMPACT OF FATIGUE ON PATIENTS WITH MULTIPLE-SCLEROSIS [J].
FISK, JD ;
PONTEFRACT, A ;
RITVO, PG ;
ARCHIBALD, CJ ;
MURRAY, TJ .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1994, 21 (01) :9-14
[10]   A PROSPECTIVE-STUDY OF DEPRESSION AND IMMUNE DYSREGULATION IN MULTIPLE-SCLEROSIS [J].
FOLEY, FW ;
TRAUGOTT, U ;
LAROCCA, NG ;
SMITH, CR ;
PERLMAN, KR ;
CARUSO, LS ;
SCHEINBERG, LC .
ARCHIVES OF NEUROLOGY, 1992, 49 (03) :238-244